Showing 6861-6870 of 20413 results for "".
Understanding Variability in Myasthenia Gravis
https://reachmd.com/programs/neurofrontiers/variability-myasthenia-gravis/51016/Myasthenia gravis is an unpredictable condition, with symptoms and treatment responses that can vary widely from one patient to the next. Tune in to hear Dr. Henry Kaminski explain how to navigate this variability and make thoughtful, individualized treatment decisions. Dr. Kaminski is the Meta A. NMaking Mechanism-Based Treatment Decisions in cGVHD
https://reachmd.com/programs/project-oncology/mechanism-based-treatment-decisions-cgvhd/54337/As treatment options for chronic graft-versus-host disease (cGVHD) expand, understanding its underlying pathophysiology is critical to guiding therapy. That’s why Dr. Brian McDonough speaks with Dr. Alicia Lieberman to explore key immune drivers, including cytokine signaling, B-cell activation, andHidden Hunger in CKD: A Case-Based Perspective
https://reachmd.com/programs/clinicians-roundtable/hidden-hunger-ckd-case-based-perspective/54814/Food and nutrition insecurity in chronic kidney disease (CKD) can be difficult to detect, even when patients appear clinically stable. To help highlight this challenge, Dr. Jeanette Andrade presents a case from her research illustrating how social and financial stressors affected a dialysis patient’When Asthma and Sleep Apnea Overlap
https://reachmd.com/programs/Audioabstracts/asthma-sleep-apnea-overlap/54211/The intersection of asthma and obstructive sleep apnea may form a distinct overlap syndrome driven by shared inflammation, disrupted sleep physiology, and amplified clinical risk. Join Ryan Quigley as he unpacks the evolving science behind this condition and what it means for diagnosis, disease contRetinal Vein Occlusion in Younger Patients: Key Care Considerations
https://reachmd.com/programs/eye-on-ocular-health/retinal-vein-occlusion-in-younger-patients-key-care-considerations/54491/Retinal vein occlusion in younger patients is important to pay attention to, especially because it may be a signal of a blood clotting disorder. Join Dr. Jessica Randolph, Assistant Professor at Virginia Commonwealth University and a practicing vitreoretinal surgeon at Wagner Kapoor Institute in RicA Personalized Approach to Complex Psoriasis Cases
https://reachmd.com/programs/frontlines-psoriasis/personalized-approach-complex-psoriasis/39955/Evolving insights into Th1-, Th2-, and Th17-driven inflammation are reshaping the diagnosis and management of patients presenting with mixed psoriasis subtypes. Ryan Quigley sits down with Dr. Jenny Murase to learn more about practical approaches to personalized treatment planning, common clinical pPushing the Envelope in PN Research
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37181/Raja Sivamani, MD, MS, AP, an integrative dermatologist and Adjunct Associate Professor of Clinical Dermatology at the University of California, Davis, discusses how research to help understand different aspects of prurigo nodularis can help develop therapeutics that can be life-changing for patientModern Approaches to Psoriatic Arthritis Management
https://reachmd.com/programs/living-rheum/modern-approaches-to-psoriatic-arthritis-management/56348/The treatment landscape for psoriatic arthritis has expanded significantly, offering a range of targeted therapies with varying mechanisms of action. Tune in to hear Dr. Lawrence H. Brent discuss how clinicians can individualize treatment decisions based on disease manifestations, comorbidities, andUnpacking the Complexity of Psoriatic Arthritis
https://reachmd.com/programs/living-rheum/unpacking-the-complexity-of-psoriatic-arthritis/56346/Psoriatic arthritis is a highly heterogeneous disease with diverse clinical presentations, ranging from mild joint involvement to severe, deforming arthritis and axial disease. Join Dr. Lawrence H. Brent as he explores the varied manifestations and comorbidities that complicate diagnosis and managemAI-Driven Advances in ATTR-CM Care
https://reachmd.com/programs/heart-matters/ai-advances-attr-cm-care/49058/Artificial intelligence has rapidly advanced disease recognition in transthyretin amyloid cardiomyopathy (ATTR-CM), and its role in guiding treatment selection, predicting progression, and refining prognosis is now being explored. Discover what's next in ATTR-CM care with Dr. Frederick Ruberg, Chief